In the United States, the management of glaucoma costs about $2.5 billion per year. Of the $1.9 billion in direct costs, glaucoma medications account for an estimated 38% to 52% of the total. In an article published in the January 2008 issue of the American Journal of Ophthalmology, researchers from The Texas A&M University System [...]
Study Compares Two Common Glaucoma Medications
A multinational study group including ophthalmologists from Finland, Germany, Ireland, Spain, and the United Kingdom recently reported the results of their study comparing Xalatan (latanoprost) and Alphagan (brimonidine) at the European Glaucoma Society meeting. The study group sought to determine both effectiveness and safety of the two commonly used glaucoma [...]
